Bio Compression Systems, Inc. appears in FDA premarket records as the applicant for sequential circulator pumps intended for segmental pneumatic compression. The company's own published device pages describe digital, segmental pumps with four or eight chambers that deliver gradient pressure, and its operating instructions carry the line "Quality Medical Products Since 1983." The documented record for this profile centers on one recent clearance and the product documentation that accompanies the SC-4004-DL and SC-4008-DL models. [1][5][6][7][4]

The September 2026 clearance

FDA records linked by MedtechLedger show K261807, a Traditional 510(k) with a decision of Substantially Equivalent dated September 11, 2026, received June 1, 2026, reviewed in the Cardiovascular advisory committee. The FDA database entry names the device as Sequential Circulator (SC-4004-DL, SC-4008-DL) under product code JOW, device class 2, regulation 870.5800, with the applicant listed as Bio Compression Systems, Inc. of Moonachie, New Jersey. The clearance letter for the same number describes the trade device as Sequential Circulator (SC-4104-DL, SC-4108-DL) and identifies Marc Somelofski as Vice President of RA/QA. [1][3]

The supplied collection holds one linked record, a 510(k), with a decision count of one Substantially Equivalent. That count describes this as-of snapshot of filings, not the company's total portfolio, sales or safety record. [1]

Documented pump models and specifications

The manufacturer's product pages describe the SC-4004-DL as a 4 chamber system and the SC-4008-DL as an 8 chamber system, each with unilateral or bilateral capability, a touch screen LCD, adjustable pressure between 10 mmHg and 120 mmHg in all chambers, and adjustable cycle time between 60 and 120 seconds in 15 second increments. Both pages list a countdown timer or continuous mode, a pause button, a compliance meter, a 3 year warranty and HCPCS code E0652. The SC-4004-DL page lists focus therapy; the SC-4008-DL page lists pre-therapy mode and focus therapy. Listed dimensions are 4.5 by 12 by 7.34 inches, with weight given as 3.5 lbs for the 4 chamber unit and 3.85 lbs for the 8 chamber unit. [5][6]

The company's device overview describes its pneumatic compression devices as digital, segmental pumps with 4 or 8 chambers that apply gradient pressure, and states that a non-peristaltic action moves fluid from distal to proximal. The operating instructions list package contents as the sequential circulator pump, power cord, instructions for use, blocker bar and garment or garments. [7][4]

Earlier filing scope and labeling

An earlier clearance letter, K210417 dated May 14, 2021, covers Sequential Circulators SC-1004-DL, SC-1008-DL, SC-2004-DL, SC-2008-DL, SC-4004-DL and SC-4008-DL under the same regulation and product code, and its summary describes primary or adjunctive treatment of lymphedema, peripheral edema, lipedema, venous insufficiency and venous stasis ulcers. That letter is a separate filing from K261807 and is not part of the linked record count. [8]

The operating instructions for the SC-4004-DL and SC-4008-DL identify Bio Compression Systems, Inc. at 120 West Commercial Avenue, Moonachie, NJ as manufacturer, with telephone, toll-free number, email and website contacts, and name Emergo Consulting (UK) Limited as UK Responsible Person. The FDA clearance letter uses the same New Jersey street address for correspondence; a filing address is not treated here as a verified headquarters. [9][3]

What the record does not establish

No parent company, brand ownership, customer list or independent clinical testing is documented in these sources. The manufacturer's pages state health benefits and contraindication pointers that reference the product manual; those statements are the manufacturer's own published claims, and the manual's warnings, precautions and contraindications are not reproduced here. [5][6]